BioLineRx (BLRX) Reports In-Line Q2 EPS

August 14, 2025 7:14 AM EDT

BioLineRx (NASDAQ: BLRX) reported Q2 EPS of $0.00. Revenue for the quarter came in at $5.39 million.

For earnings history and earnings-related data on BioLineRx (BLRX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK